Gen1E Lifesciences Company
GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.
Investors
Technology:
Geroscience
Industry:
AI, Biotechnology, End-to-end Drug Development, Life Science, United States
Headquarters:
Palo Alto, California, United States
Founded Date:
2018-01-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
7
Total Funding:
17025023
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-12-21
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership